TPTX - Turning Point Therapeutics GAAP EPS of -$2.48 misses by $0.78 revenue of $0.12M misses by $2.15M August, 08 2022 04:46 PM Turning Point Therapeutics Inc. Turning Point Therapeutics press release ( NASDAQ: TPTX ): Q2 GAAP EPS of -$2.48 misses by $0.78 . Revenue of $0.12M (-97.7% Y/Y) misses by $2.15M . For further details see: Turning Point Therapeutics GAAP EPS of -$2.48 misses by $0.78, revenue of $0.12M misses by $2.15M